摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N'-Cbz-L-鸟氨酸 | 3304-51-6

中文名称
N'-Cbz-L-鸟氨酸
中文别名
N’-Cbz-L-鸟氨酸;N'-苄氧羰基-L-鸟氨酸;苄氧羰基-L-鸟氨酸;N"-Cbz-L-鸟氨酸;N"-苄氧羰基-L-鸟氨酸
英文名称
N-carboxybenzyl-L-ornithine
英文别名
Nδ-(benzyloxycarbonyl)-L-ornithine;Nδ-Benzyloxycarbonyl-L-ornithin;N-benzyloxycarbonyl-L-ornithine;N'-Cbz-L-ornithine;H-Orn(Z)-OH;(2S)-2-amino-5-(benzyloxycarbonylamino)pentanoic acid;benzyloxycarbonyl-L-ornithine;(2S)-2-amino-5-(phenylmethoxycarbonylamino)pentanoic acid
N'-Cbz-L-鸟氨酸化学式
CAS
3304-51-6
化学式
C13H18N2O4
mdl
MFCD00037220
分子量
266.297
InChiKey
VULSXQYFUHKBAN-NSHDSACASA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    248-252℃
  • 沸点:
    492.2±45.0 °C(Predicted)
  • 密度:
    1.234±0.06 g/cm3(Predicted)
  • 溶解度:
    酸性酒精(微溶)、酸溶液(微溶)

计算性质

  • 辛醇/水分配系数(LogP):
    -0.8
  • 重原子数:
    19
  • 可旋转键数:
    7
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.384
  • 拓扑面积:
    106
  • 氢给体数:
    2
  • 氢受体数:
    4

安全信息

  • WGK Germany:
    3
  • 海关编码:
    2924299090
  • 危险性防范说明:
    P261,P280,P305+P351+P338
  • 危险性描述:
    H302,H315,H319,H332,H335
  • 储存条件:
    -20°C

SDS

SDS:b185b123c503339f4b8cc7bee149fd06
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: H-Orn(Z)-OH
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: H-Orn(Z)-OH
CAS number: 3304-51-6

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C13H18N2O4
Molecular weight: 266.3

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

N'-Cbz-L-鸟氨酸是一种氨基酸衍生物,可用作有机合成中间体和医药中间体,主要用于实验室研发过程和化工生产过程中。

制备方法: 将5.0克(29.7毫摩尔)L-鸟氨酸盐酸盐溶解在含50毫升0.5M氢氧化钠水溶液中,然后加入100毫升含有2.8克(17.8毫摩尔)硫酸铜的水溶液。混合物在室温下搅拌4小时后冷却至0℃,随后加入5.0克(59.4毫摩尔)碳酸氢钠和5.7毫升(40.1毫摩尔)氯甲酸苄酯。

逐步通过滴加1.0M的氢氧化钠水溶液将pH调节到约9,并在室温下继续搅拌4小时。随后过滤并收集所得固体,用少量水洗涤后,再用乙醚洗涤。固体溶于200毫升0.5M EDTA水溶液中,在室温下剧烈搅拌14小时。最后再次过滤收集固体并用水洗涤,即可得到粗制N'-Cbz-L-鸟氨酸,无需进一步纯化即可使用。

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    • 1
    • 2

反应信息

  • 作为反应物:
    描述:
    N'-Cbz-L-鸟氨酸 在 palladium on activated charcoal 高氯酸氢气羟胺三氟乙酸 作用下, 以 1,4-二氧六环二氯甲烷 为溶剂, 反应 53.0h, 生成 N(5)-[(E)-氨基(羟基亚胺)甲基]-L-鸟氨酸
    参考文献:
    名称:
    Nω-羟基精氨酸的合成和生物活性:从精氨酸生物合成一氧化氮的可能中间体。
    摘要:
    DOI:
    10.1021/jm00109a032
  • 作为产物:
    描述:
    L-鸟氨酸盐酸盐 在 lithium hydroxide 、 sodium hydroxide 作用下, 生成 N'-Cbz-L-鸟氨酸
    参考文献:
    名称:
    Multigram Synthesis of NG-Methyl-(L)-Arginine and Its Analytical Characterization
    摘要:
    A multigram preparation and analytical characterization of N(G)-methyl-(L)-arginine (L-NMMA) 1, the most important inhibitor of the biosynthesis of Endothelium-Derived Relaxing Factor (EDRF), is reported.
    DOI:
    10.1080/00397919108020795
点击查看最新优质反应信息

文献信息

  • [EN] AZASULFURYLPEPTIDE-BASED CD36 MODULATORS AND USES THEREOF<br/>[FR] MODULATEURS CD36 À BASE D'AZASULFURYLPEPTIDES ET UTILISATIONS DE CEUX-CI
    申请人:RSEM LTD PARTNERSHIP
    公开号:WO2016029324A1
    公开(公告)日:2016-03-03
    Novel azasulfuryl-containing peptidomimetics capable of inhibiting CD36 activity are disclosed. Use of these azasulfuryl-containing peptidomimetics for the treatment of CD36-related diseases, disorders or conditions, including TLR2-mediated inflammatory disease, disorder or condition, and methods of obtaining such azasulfuryl-containing peptidomimetics, are also disclosed.
    揭示了能够抑制CD36活性的新型含氮硫酰基的肽类模拟物。还揭示了利用这些含氮硫酰基的肽类模拟物治疗与CD36相关的疾病、紊乱或状况,包括TLR2介导的炎症性疾病、紊乱或状况的用途,以及获取这种含氮硫酰基的肽类模拟物的方法。
  • Total synthesis and antifungal evaluation of cyclic aminohexapeptides
    作者:Larry L. Klein、Leping Li、Hui-Ju Chen、Cynthia B. Curty、David A. DeGoey、David J. Grampovnik、Christina L. Leone、Sheela A. Thomas、Clinton M. Yeung、Kenneth W. Funk、Vimal Kishore、Edwin O. Lundell、Dariusz Wodka、Jon A. Meulbroek、Jeffrey D. Alder、Angela M. Nilius、Paul A. Lartey、Jacob J. Plattner
    DOI:10.1016/s0968-0896(00)00097-3
    日期:2000.7
    fungal infections continues to rise. Naturally occurring hexapeptide echinocandin B (1) has shown potent antifungal activity via its inhibition of the synthesis of beta-1,3 glucan, a key fungal cell wall component. Although this series of agents has been limited thus far based on their physicochemical characteristics, we have found that the synthesis of analogues bearing an aminoproline residue in the
    对治疗全身性真菌感染的新疗法的需求持续增长。天然存在的六肽棘皮菌素B(1)通过抑制β-1,3葡聚糖(一种重要的真菌细胞壁成分)的合成,显示出强大的抗真菌活性。尽管到目前为止,由于该试剂的理化特性而受到限制,但我们发现在“西北”位置带有氨基脯氨酸残基的类似物的合成可大大改善水溶性(> 5 mg / mL)。报道了基于整个细胞和一系列化合物的体内活性的合成和构效关系(SAR)。
  • Polypeptides. Part V. The use of t-butyl 2,4,5-trichlorophenyl carbonate in the synthesis of N-t-butoxycarbonyl amino-acids and their 2,4,5-trichlorophenyl esters
    作者:Wallace Broadbent、J. S. Morley、B. E. Stone
    DOI:10.1039/j39670002632
    日期:——
    t-Butyl 2,4,5-trichlorophenyl carbonate, conveniently prepared from phosgene in two stages, reacts cleanly with amino-acids in the presence of bases to give N-t-butoxycarbonyl amino-acids (and 2,4,5-trichlorophenol) in excellent yield. By co-extraction of the N-t-butoxycarbonyl amino-acid and 2,4,5-trichlorophenol from the acidified reaction mixture, followed by treatment of the extracts with NN′-
    碳酸叔丁酯2,4,5-三氯苯甲酸,方便地从光气中分两步制备,在碱的存在下与氨基酸干净地反应,得到N-叔丁氧羰基氨基酸(和2,4,5-三氯苯酚)的良率。由的共萃取Ñ -t丁氧羰基氨基酸及从所述酸化反应混合物2,4,5-三氯苯酚,接着处理所述提取物的具有NN '-dicyclohexylcarbodi酰亚胺,相应的高收率Ñ -t得到-丁氧基羰基氨基酸2,4,5-三氯苯基酯。这些活性酯大部分是稳定的结晶固体,可以方便地用于肽合成中。
  • Peptide Synthesis in Aqueous Solution. IV. Preparation and Properties of [<i>p</i>-(Benzyloxycarbonyloxy)phenyl]dimethylsulfonium Methyl Sulfate (Z-ODSP), [<i>p</i>-(<i>t</i>-Butoxycarbonyloxy)phenyl]dimethylsulfonium Methyl Sulfate (Boc-ODSP) and [<i>p</i>-(9-Fluorenylmethyloxycarbonyloxy)phenyl]dimethylsulfonium Methyl Sulfate (Fmoc-ODSP) as Water-Soluble<i>N</i>-Acylating Reagents
    作者:Ikunori Azuse、Masahiro Tamura、Keisuke Kinomura、Hideo Okai、Katsushige Kouge、Fumio Hamatsu、Tatsuya Koizumi
    DOI:10.1246/bcsj.62.3103
    日期:1989.10
    order to increase the applications of the water-soluble active ester method, water-soluble acylating reagents, [p-(benzyloxycarbonyloxy)phenyl]dimethylsulfonium methyl sulfate, [p-(t-butoxycarbonyloxy)phenyl]dimethylsulfonium methyl sulfate and [p-(9-fluorenylmethyloxycarbonyloxy)phenyl]dimethylsulfonium methyl sulfate, were synthesized from of p-hydroxyphenyldimethylsulfonium methyl sulfate. These
    为了增加水溶性活性酯法的应用,水溶性酰化试剂[对(苄氧基羰基氧基)苯基]二甲基硫酸锍、[对(叔丁氧基羰氧基)苯基]二甲基硫酸锍和[对- (9-芴基甲氧基羰基氧基)苯基]二甲基锍甲基硫酸盐由对羟基苯基二甲基锍甲基硫酸盐合成。这些化合物在水中具有高溶解度(超过 30%),并且被发现可作为优异的水溶性酰化试剂,用于在水溶液中合成 N-苄氧羰基、N-叔丁氧羰基、N-9-芴基甲氧羰基氨基酸衍生物。他们在水性介质和氨基酸中将二肽转化为 N-酰基二肽。此外,还发现它们是保护赖氨酸、鸟氨酸、
  • Studies of Peptide Antibiotics. I. Dipeptide Anhydrides as Models of Cyclic Peptide Antibiotics
    作者:Nobuo Izumiya、Tetsuo Kato、Yoshimasa Fujita、Motonori Ohno、Michio Kondo
    DOI:10.1246/bcsj.37.1809
    日期:1964.12
    The D-D, L-L, D-L and L-D stereomers of both valyllysine anhydride and phenylalanyllysine anhydride, and the D-L and L-L stereomers of both valylornithine anhydride and phenylalanylornithine anhydride, have been synthesized in order to compare them with the cyclic peptide antibiotics, with which they possess several structural features in common. Synthesis has been achiveved by the dicyclohexylcarbodiimide-induced
    合成了缬氨酰酐和苯丙赖氨酸酐的 DD、LL、DL 和 LD 立体异构体,以及缬氨酰鸟氨酸酐和苯丙氨酸酐酐的 DL 和 LL 立体异构体,以便与环肽类抗生素进行比较。共同的结构特点。合成是通过二环己基碳二亚胺诱导的甲酰基(或叔丁氧羰基)缬氨酸(或苯丙氨酸)与 ω-羧基苯甲氧基赖氨酸(或鸟氨酸)酯的缩合,然后在甲醇中用氯化氢处理所得酰基二肽酯来实现的或乙酸乙酯去除甲酰基或叔丁氧羰基保护基团。如此衍生的二肽酯盐酸盐已在氨的作用下转化为相应的苯甲氧基取代的二肽酸酐,而这些又通过钯催化的氢解转化为所需的未酰化的二肽酸酐盐酸盐。酶解...
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐